Physician profile
Stephen L Phillips
NPI 1912993593
$1,984.40
in general payments reported to CMS, 2019-2025
17 companies · $387 in 2025
The $387 reported for 2025 was more than what 90% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $174 · 2021: $172 · 2022: $330 · 2023: $404 · 2024: $362 · 2025: $387.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,152.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $538.94 | 2022-2025 | Azstarys |
| Glaxosmithkline, LLC. | $298.29 | 2019-2024 | Bexsero |
| Ironshore Pharmaceuticals INC. | $191.16 | 2020-2024 | Jornay Pm |
| Neos Therapeutics, LP | $131.89 | 2019-2024 | Cotempla Xr-Odt |
| Sanofi-Aventis U.S. LLC | $119.32 | 2025 | |
| Tris Pharma INC | $97.72 | 2019-2022 | |
| Cranial Technologies, INC | $82.93 | 2021-2025 | Doc Band |
| Sanofi Pasteur INC. | $82.22 | 2019-2024 | |
| Aytu Biopharma, INC. | $77.96 | 2020-2022 | |
| Pfizer INC. | $72.86 | 2019-2024 | |
| Seqirus USA INC | $60.23 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $52.96 | 2021-2024 | Flumist Quadrivalent |
| Takeda Pharmaceuticals U.S.A., INC. | $52.73 | 2019-2021 | |
| Sobi, INC | $45.84 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $45.55 | 2025 | Vaxneuvance, Rotateq, Vaxelis |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $17.75 | 2025 | Jornay Pm |
| Arbor Pharmaceuticals, INC. | $16.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.